logo
New, possibly deadly virus found in Alabama animals. Here's what we know so far

New, possibly deadly virus found in Alabama animals. Here's what we know so far

Yahoo05-02-2025

A new animal-borne virus has been discovered in Alabama. But the creature that carries it can be found along parts of the Atlantic seaboard, as far north as southern Saskatchewan, Canada, as far south as the Gulf states and as far west as Kansas.
A group of researchers from the The University of Queensland in Australia have identified a new strain of henipavirus in North America, the first found in the continent.
'Henipaviruses have caused serious disease and death in people and animals in other regions,' Dr. Rhys Parry of the UQ School of Chemistry and Molecular Biosciences said in a release from the university.
This strain is called Camp Hill, named for the place near Auburn, Alabama, where four infected northern short-tailed shrews were caught in 2021.
'The discovery of a henipavirus in North America is highly significant, as it suggests these viruses may be more globally distributed than previously thought.," Parry said.
Here's what we know so far about the new illness.
The Alabama Department of Conservation and Natural Resources data shows these animals are also called:
Short-tailed Blarina.
Mole Shrew.
Large Short-tailed Shrew.
According to the National Park Service, these shrews are about 4 inches long and weigh about an ounce. They're insectivores in the same family of animals as moles, and they aren't rodents like mice or rats.
They spend most of their time underground or in leaf litter and use echolocation to move in the dark.
These shrews have venomous saliva that's enough to paralyze or kill some prey. Because the shrew doesn't have fangs, it introduces the neurotoxin by chewing or gnawing on its intended victim.
What to know about Journavx: FDA approves new pain medication as an alternative to opioids
'The closest known henipavirus to Camp Hill virus that has caused disease in humans is Langya virus, which crossed from shrews to humans in China,' Parry said.
'This indicates that shrew-to-human transmission can occur.'
Shrews are considered the primary carrier for Langya, but it's also been found in goats and dogs.
"Given the high case-fatality rates associated with henipaviruses, detection of CHV in North America raises concerns about past and potential future spillover events. Further investigation is needed into the potential for human infection and strategies for mitigating transmission," reads the research letter published in Emerging Infectious Diseases.
'Henipaviruses have caused serious disease and death in people and animals in other regions,' Parry said.
He said the Hendra virus has a 70% fatality rate, and Nipah has "recorded fatality rates between 40 and 75 per cent in outbreaks in South-East Asia, including in Malaysia and Bangladesh."
They can cause respiratory distress and encephalitis.
No fatalities were reported from Langya, but infected people did reportedly have:
Fever.
Fatigue.
Cough.
Impaired liver or kidney funtion.
According to information from the CDC, henipaviruses are single-strand RNA viruses that can infect humans. Of six that were previously identified, "Hendra virus and Nipah virus are highly virulent emerging pathogens that cause outbreaks in humans and are associated with high case-fatality ratios."
The CDC has it listed as a travel-association infection primarily found in other countries:
Nipah virus: Southeast Asia and Bangladesh, India.
Hendra virus: Austrailia.
Langya virus: China.
Norovirus survival guide: How to get through the stomach flu
The CDC noted that travelers should avoid bat roosting areas and practice food safety to avoid food contaminated by infected animals.
Flying fox bats are known to be carriers, and horses exposed to bat urine can infect people.
More research was needed, according to the CDC, to see how Langya virus was transferred to humans from shrews.
Dr. Ariel Isaacs, who co-authored the research, said developing a vaccines for this virus family is an important next step in the UQ news release.
'The next step for this work is to characterise key surface proteins on the virus that are involved in cell entry to broaden our understanding of the virus family and identify better ways to protect against it,' Isaacs said.
The infected animals also carried Camp Ripley Virus, a hantavirus previously found in northern short-tailed shrews.
Hantavirus is commonly carried by rodents and can be spread to people via infected urine, feces or saliva and can be made airborne while cleaning. According to the New York Department of Health, it can't be spread from person to person.
Hantavirus can be deadly with symptoms possibly showing up weeks after infection. Early symptoms can look like fever, fatigue and muscle pain. More advanced infections might include headache, diarrhea, dizziness and nausea/vomiting. The main issue is fluid buildup in the lungs.
It can be diagnosed with a blood test. Seek medical attention quickly if you have symptoms and think you've been exposed.
Bonnie Bolden is a Deep South Connect reporter with Gannett/USA Today. Email her at bbolden@gannett.com.
This article originally appeared on Montgomery Advertiser: New strain of possibly deadly virus found in Alabama wild animals

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Increased screen time linked to aggression, anxiety, low self-esteem in kids, study finds
Increased screen time linked to aggression, anxiety, low self-esteem in kids, study finds

Yahoo

timea day ago

  • Yahoo

Increased screen time linked to aggression, anxiety, low self-esteem in kids, study finds

A major international study looking at nearly 300,000 children has revealed a two-way link between the amount of time kids spend on screens and their emotional and social well-being. Children who spent more time using devices like TVs, tablets, computers, and gaming consoles were at a higher risk of developing problems like aggression, anxiety, and low self-esteem later in life, the study found. The connection also works in reverse: Children who were already struggling with social or emotional challenges tended to spend more time on all types of screens. Time spent on gaming consoles was particularly linked to a greater chance of developing issues, according to the study, published Monday in the academic journal Psychological Bulletin. Excessive screen time during infancy may be linked to lower cognitive skills later in childhood "Rather than breaking it down by the exact game people were playing, it's safe to make some assumptions," Dr. Michael Noetel, one of the study's authors and associate professor of psychology at The University of Queensland, Australia, told ABC News. "The most games that were included were console games, computer games and mobile games." When asked if violent games, such games that involved shooting, led to more behavioral issues, Noetel said that was not necessarily the case. "Some studies broke the games down by whether they were violent, but our interpretation was that most parents knew to limit the amount of violent content to give kids under 10," he said. "Instead, [the] key finding was that gaming in general -- regardless of the specific type -- showed much stronger links to emotional problems than other screen activities like watching TV or using educational apps." The study is one of the largest of its kind, analyzing 117 long-term studies conducted between 1972 and 2024. By focusing on children aged 10 and under and tracking them over time, the researchers could more clearly determine cause and effect. The American Academy of Pediatrics recommends children between the ages of 2 and 5 to limit recreational screen time to one hour per day on weekdays and three hours on weekends. Children who exceed recommended screen time guidelines were more prone to socioemotional issues compared to those who stayed within the recommended limits, according to the study. "More than 40% of kids [ages] 8 to 12 are using screens for more than four hours per day," Dr. Tara Narula, ABC News chief medical correspondent, said about the study's findings Tuesday on "Good Morning America." "You add to that the fact that we are seeing rising rates of mental health disorders in kids, and half of these disorders start before the age of 14 -- you can understand why we need to understand the effects of screens on our kids." 48-hour screen-time experiment: What happens when kids have no limits So, what's the key takeaway for parents? The goal isn't to eliminate screens entirely, the study authors said. When children engage in moderate amounts of screen time, especially for educational purposes, there is a lower risk for social or emotional problems in the future. Children should learn not to use a screen as their sole outlet to manage their emotions and should be encouraged to interact with friends and family to develop resilience and emotional skills. The most important thing is to ensure that screen time doesn't interfere with essentials like a full night's sleep and regular physical activity, the study added. "We've all been guilty of it, but it's OK to say no and to set limits and boundaries, and do it in a noncontrolling way as a parent, if you can," said Narula, who was not involved with the study. Dr. Brendan Huang serves as the chief resident physician in adult neurology at Northwell Health and is also a member of the ABC News Medical Unit. Increased screen time linked to aggression, anxiety, low self-esteem in kids, study finds originally appeared on

Increased screen time linked to aggression, anxiety, low self-esteem in kids, study finds

time2 days ago

Increased screen time linked to aggression, anxiety, low self-esteem in kids, study finds

A major international study looking at nearly 300,000 children has revealed a two-way link between the amount of time kids spend on screens and their emotional and social well-being. Children who spent more time using devices like TVs, tablets, computers, and gaming consoles were at a higher risk of developing problems like aggression, anxiety, and low self-esteem later in life, the study found. The connection also works in reverse: Children who were already struggling with social or emotional challenges tended to spend more time on all types of screens. Time spent on gaming consoles was particularly linked to a greater chance of developing issues, according to the study, published Monday in the academic journal Psychological Bulletin. "Rather than breaking it down by the exact game people were playing, it's safe to make some assumptions," Dr. Michael Noetel, one of the study's authors and associate professor of psychology at The University of Queensland, Australia, told ABC News. "The most games that were included were console games, computer games and mobile games." When asked if violent games, such games that involved shooting, led to more behavioral issues, Noetel said that was not necessarily the case. "Some studies broke the games down by whether they were violent, but our interpretation was that most parents knew to limit the amount of violent content to give kids under 10," he said. "Instead, [the] key finding was that gaming in general -- regardless of the specific type -- showed much stronger links to emotional problems than other screen activities like watching TV or using educational apps." The study is one of the largest of its kind, analyzing 117 long-term studies conducted between 1972 and 2024. By focusing on children aged 10 and under and tracking them over time, the researchers could more clearly determine cause and effect. The American Academy of Pediatrics recommends children between the ages of 2 and 5 to limit recreational screen time to one hour per day on weekdays and three hours on weekends. Children who exceed recommended screen time guidelines were more prone to socioemotional issues compared to those who stayed within the recommended limits, according to the study. "More than 40% of kids [ages] 8 to 12 are using screens for more than four hours per day," Dr. Tara Narula, ABC News chief medical correspondent, said about the study's findings Tuesday on " Good Morning America." "You add to that the fact that we are seeing rising rates of mental health disorders in kids, and half of these disorders start before the age of 14 -- you can understand why we need to understand the effects of screens on our kids." So, what's the key takeaway for parents? The goal isn't to eliminate screens entirely, the study authors said. When children engage in moderate amounts of screen time, especially for educational purposes, there is a lower risk for social or emotional problems in the future. Children should learn not to use a screen as their sole outlet to manage their emotions and should be encouraged to interact with friends and family to develop resilience and emotional skills. The most important thing is to ensure that screen time doesn't interfere with essentials like a full night's sleep and regular physical activity, the study added. "We've all been guilty of it, but it's OK to say no and to set limits and boundaries, and do it in a noncontrolling way as a parent, if you can," said Narula, who was not involved with the study.

1 Underrated Reason to Buy This Market-Beating Stock
1 Underrated Reason to Buy This Market-Beating Stock

Yahoo

time04-06-2025

  • Yahoo

1 Underrated Reason to Buy This Market-Beating Stock

Eli Lilly recently acquired a smaller biotech for its promising investigational pain medication. The company generates strong sales from products outside of diabetes and obesity care. Eli Lilly's portfolio, both within and outside its core area, makes the stock attractive. 10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY) has been one of the top-performing healthcare megacap stocks of the past decade. And in more recent years, particularly over the past five, it's easy to point to the biggest factor driving Eli Lilly's run: The company's work in diabetes and, especially, the weight loss market. Eli Lilly is unquestionably one of the two leaders in this fast-growing field, and it appears to be gaining ground on its biggest competitor, Novo Nordisk. However, a recent move Eli Lilly made reveals an underrated reason why the stock has attractive prospects. Here's what investors should know. On May 27, Eli Lilly announced it would dish out $1 billion in cash to acquire SiteOne Therapeutics, a privately held biotech. The key asset from this transaction is STC-004, a mid-stage investigational non-opioid oral pain medicine. Though there are treatment options for chronic pain, non-opioid ones could become increasingly popular since opioid-based therapies often carry significant side effects. Meanwhile, this market is brand new. In January, Vertex Pharmaceuticals earned approval from the U.S. Food and Drug Administration for Journavx, the first non-opioid oral pain inhibitor. Eli Lilly is looking to make waves in this market with the acquisition of SiteOne Therapeutics. The transaction may or may not pan out. Perhaps STC-004 will flop in upcoming clinical trials. But there's something important to highlight about Eli Lilly that this acquisition brings to light. This move is hardly out of the ordinary for Eli Lilly. One thing that sets it apart from Novo Nordisk is that, while the latter generates more than 90% of its revenue from its diabetes or obesity medicines, Eli Lilly's lineup of drugs features some major blockbusters outside this area. In the first quarter, the company's revenue grew 45% year over year to $12.73 billion. Eli Lilly's cancer drug Verzenio racked up $1.2 billion in sales, up 10% year over year. The company's immunosuppressant, Taltz, generated $762 million in revenue, a 26% increase over the year-ago period. Eli Lilly's sales outside of diabetes and obesity products accounted for almost 28% of its top line. That might not exactly be peak diversification, but Eli Lilly fares better than its eternal rival, Novo Nordisk, in this department. Furthermore, the company's newer products also feature several that fall outside its core area of expertise. These include Kisunla in Alzheimer's disease, Jaypirca in oncology, and Ebglyss, an eczema treatment. The same can be said about Eli Lilly's pipeline. Consider the company's investigational gene therapy for genetic deafness, as well as its several dozen programs in oncology. To be clear, Eli Lilly's diabetes and weight management medicines should continue occupying the role of main growth drivers. In the first quarter, Mounjaro's revenue soared by 113% year over year to $3.8 billion. Zepbound's sales came in at $2.3 billion, representing a 347% increase compared to the first quarter of 2024. Neither has peaked yet. Considering analyst projections for the GLP-1 market, they will continue growing their sales at an incredible clip at least through the end of the decade. And there is more where that came from, too. Eli Lilly is developing newer medicines in this area. The company's investigational oral GLP-1 therapy, orforglipron, recently aced a phase 3 study. According to management, the drugmaker has a total of 11 obesity pipeline candidates. So, Eli Lilly's work in this field will remain one of the major keys to its success. Perhaps it is what will get many investors nowadays interested in the stock. However, Eli Lilly is also a diversified pharmaceutical giant with a strong portfolio of medicines and promising candidates in oncology, immunology, and other areas. So, even with mounting competition in the GLP-1 market, Eli Lilly remains attractive, not just because it is likely to develop better anti-obesity medicines than most of its competitors, but because it is a leader in other markets as well. That's another excellent reason to invest in Eli Lilly and hold on to its shares for a long time. Before you buy stock in Eli Lilly, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Eli Lilly wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $657,385!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $842,015!* Now, it's worth noting Stock Advisor's total average return is 987% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Prosper Junior Bakiny has positions in Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Vertex Pharmaceuticals. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. 1 Underrated Reason to Buy This Market-Beating Stock was originally published by The Motley Fool Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store